Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

CONTEXT: Novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) tirzepatide demonstrated substantially greater glucose control and weight loss (WL) compared with selective GLP-1RA dulaglutide. OBJECTIVE: Explore mechanisms of glucose c...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Melissa K, Nikooienejad, Amir, Bray, Ross, Cui, Xuewei, Wilson, Jonathan, Duffin, Kevin, Milicevic, Zvonko, Haupt, Axel, Robins, Deborah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823251/
https://www.ncbi.nlm.nih.gov/pubmed/33236115
http://dx.doi.org/10.1210/clinem/dgaa863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823251/
https://www.ncbi.nlm.nih.gov/pubmed/33236115
http://dx.doi.org/10.1210/clinem/dgaa863

Ejemplares similares